Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

One year in review 2017: novelties in the treatment of rheumatoid arthritis.

Ferro F, Elefante E, Luciano N, Talarico R, Todoerti M.

Clin Exp Rheumatol. 2017 Sep-Oct;35(5):721-734. Epub 2017 Sep 13. Review.

2.

Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors.

Monti S, Todoerti M, Codullo V, Favalli EG, Biggioggero M, Becciolini A, Montecucco C, Caporali R.

Mod Rheumatol. 2017 Sep 7:1-8. doi: 10.1080/14397595.2017.1367076. [Epub ahead of print]

PMID:
28880727
3.

Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors.

Manzo A, Benaglio F, Vitolo B, Bortolotto C, Zibera F, Todoerti M, Alpini C, Bugatti S, Caporali R, Calliada F, Montecucco C.

Arthritis Res Ther. 2016 Oct 22;18(1):242.

4.

Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study.

Varisco V, Viganò M, Batticciotto A, Lampertico P, Marchesoni A, Gibertini P, Pellerito R, Rovera G, Caporali R, Todoerti M, Covelli M, Notarnicola A, Atzeni F, Sarzi-Puttini P.

J Rheumatol. 2016 May;43(5):869-74. doi: 10.3899/jrheum.151105. Epub 2016 Feb 15.

PMID:
26879359
5.

Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration.

Bianchi G, Caporali R, Todoerti M, Mattana P.

Adv Ther. 2016 Mar;33(3):369-78. doi: 10.1007/s12325-016-0295-8. Epub 2016 Feb 4. Review.

6.

Switching from Intravenous to Subcutaneous Formulation of Abatacept: Different Results in a Series of 21 Patients.

Monti S, Breda S, Grosso V, Todoerti M, Montecucco C, Caporali R.

J Rheumatol. 2015 Oct;42(10):1993-4. doi: 10.3899/jrheum.150230. No abstract available.

PMID:
26429207
7.

Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.

Nard FD, Todoerti M, Grosso V, Monti S, Breda S, Rossi S, Montecucco C, Caporali R.

World J Hepatol. 2015 Mar 27;7(3):344-61. doi: 10.4254/wjh.v7.i3.344. Review.

8.

Oral low-dose glucocorticoids should be included in any recommendation for the use of non-biologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis.

Caporali R, Todoerti M, Scirè CA, Montecucco C, Cutolo M.

Neuroimmunomodulation. 2015;22(1-2):104-11. doi: 10.1159/000362730. Epub 2014 Sep 12. Review.

PMID:
25227117
9.

Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis.

Todoerti M, Maglione W, Bernero E, Bortoluzzi A, Colaci M, Galuppi E, Paolino S, Talarico R, Cutolo M, Ferri C, Trotta F, Bombardieri S, Montecucco CM, Sinigaglia L.

Reumatismo. 2013 Dec 18;65(5):207-18. doi: 10.4081/reumatismo.2013.207. Review.

PMID:
24399184
10.

The role of low-dose glucocorticoids for rheumatoid arthritis in the biologic era.

Caporali R, Scirè CA, Todoerti M, Montecucco C.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4 Suppl 78):S9-13. Epub 2013 Oct 3. Review.

PMID:
24129129
11.

Drug survival of the first course of anti-TNF agents in patients with rheumatoid arthritis and seronegative spondyloarthritis: analysis from the MonitorNet database.

Scirè CA, Caporali R, Sarzi-Puttini P, Frediani B, Di Franco M, Tincani A, Sinigaglia L, Sfriso P, Tirri R, Bellis E, Delsante G, Porru G, Salaffi F, Giuggioli D, Rossini M, Todoerti M, Bazzichi L, Govoni M, Gerli R, Raschetti R, Minisola G, Montecucco C, Todesco S; Monitornet project.

Clin Exp Rheumatol. 2013 Nov-Dec;31(6):857-63. Epub 2013 Aug 26.

PMID:
23981363
12.

Glucocorticoids in rheumatoid arthritis.

Caporali R, Todoerti M, Sakellariou G, Montecucco C.

Drugs. 2013 Jan;73(1):31-43. doi: 10.1007/s40265-013-0008-4. Review.

PMID:
23335134
13.

Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis: results of a 12-month open-label randomised study.

Montecucco C, Todoerti M, Sakellariou G, Scirè CA, Caporali R.

Arthritis Res Ther. 2012 May 14;14(3):R112. doi: 10.1186/ar3838.

14.

Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs.

Bugatti S, Manzo A, Benaglio F, Klersy C, Vitolo B, Todoerti M, Sakellariou G, Montecucco C, Caporali R.

Arthritis Res Ther. 2012 Feb 15;14(1):R34. doi: 10.1186/ar3742.

15.

Recommendations for the use of biologic therapy from the Italian Society for Rheumatology: off-label use.

Todoerti M, Pipitone N, Matucci-Cerinic M, Montecucco C, Caporali R; Italian Society for Rheumatology.

Clin Exp Rheumatol. 2011 May-Jun;29(3 Suppl 66):S42-62. Epub 2011 Jul 26. Review.

PMID:
21906426
16.

Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography.

Manzo A, Caporali R, Vitolo B, Alessi S, Benaglio F, Todoerti M, Bugatti S, Calliada F, Montecucco C.

Rheumatology (Oxford). 2011 Aug;50(8):1395-400. doi: 10.1093/rheumatology/ker076. Epub 2011 Mar 4.

PMID:
21378108
17.

Early disease control by low-dose prednisone comedication may affect the quality of remission in patients with early rheumatoid arthritis.

Todoerti M, Scirè CA, Boffini N, Bugatti S, Montecucco C, Caporali R.

Ann N Y Acad Sci. 2010 Apr;1193:139-45. doi: 10.1111/j.1749-6632.2009.05367.x.

PMID:
20398020
18.

Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse.

Scirè CA, Montecucco C, Codullo V, Epis O, Todoerti M, Caporali R.

Rheumatology (Oxford). 2009 Sep;48(9):1092-7. doi: 10.1093/rheumatology/kep171. Epub 2009 Jun 26.

PMID:
19561156

Supplemental Content

Loading ...
Support Center